期刊文献+

健择联合顺铂治疗蒽环类和(或)紫杉类化疗后复发性乳腺癌34例

Gemcitabine Plus Cisplatin for Treatment of 34 Cases with Recurrent Breast Cancer after Anthracycines and/or Taxanes Chemotherapy
原文传递
导出
摘要 [目的]探讨健择联合顺铂治疗蒽环类和(或)紫杉类化疗后的复发性乳腺癌。[方法]34例经蒽环类和(或)紫杉类化疗后的复发性乳腺癌患者,采用健择1000mg/m2,第1d、8d静脉滴注;顺铂80mg/m2,第8d静脉滴注,3~4周为1个疗程。所有病例均化疗4个疗程以上。[结果]完全缓解(CR)2例,部分缓解(PR)14例,有效率47.06%(16/34)。主要毒副反应为白细胞及血小板减少。[结论]健择联合顺铂治疗蒽环类和(或)紫杉类耐药复发性乳腺癌疗效高,毒副反应可耐受。
出处 《肿瘤学杂志》 CAS 2009年第4期359-360,共2页 Journal of Chinese Oncology
  • 相关文献

参考文献3

  • 1徐兵河,李凯,刘端琪,李文辉,认宏轩.吉西他滨联合顺铂治疗50例蒽环类耐药性晚期乳腺癌[J].中国癌症杂志,2003,13(6):579-581. 被引量:57
  • 2Nagourney RA,Link JS, Blitzer JB, et al. Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients[J]. J Clin Oncol, 2000, 18 (11):2245-2249.
  • 3Mohran TZ. Gemcitabine and cisplatin combination chemotherapy as a first-line treatment in patients with metastatic breast cancer[J]. J Egypt Natl Canc Inst, 2004, 16(1): 8-14.

二级参考文献9

  • 1[1]Heinemann V. Gemcitabine plus cisplatin for the treatment of metastatic breast cancer[ J]. Clin Breast Cancer,2002,3 (Suppl 1 ): S24-S29.
  • 2[2]Seidman AD. Gemcitabine as single-agent therapy in the management of advanced breast cancer [ J ]. Oncology, 2001,15(2) (Suppl 3): 11-14.
  • 3[3]Jurga L,Misurova E, Kovac V, et al. The role of cisplatin in chemotherapy of advanced breast cancer[J]. Neoplasma, 1994,41 ( 6 ) :347-352.
  • 4[4]Carmichael J, Walling J. Advanced breast cancer:investigational role of gemcitabine[ J]. Eur J Cancer, 1997,33( Suppl 1 ): S27-S31.
  • 5[5]Pegram MD, Lipton A, Hayes DF, et al. Phase Ⅱ study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment [ J ]. J Clin Oncol, 1998, 16(8) :2659-2671.
  • 6[6]Ray-Coquard Ⅰ, Biron P, Bachelot T, et al. Vinorelbine and cisplatin ( CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline-and/or paclitaxelcontaining regimens[ J]. Cancer, 1998 ,82 ( 1 ): 134-140.
  • 7[7]Vassilomanolakis M, Koumakis G, Barbounis V, et al.Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines [ J ]. Ann Oncol, 2000,11(5) :1155-1160.
  • 8[8]Moorsel CJ, Veerman G, Bergman AM, et al. Combination chemotherapy studies with gemcitabine[ J]. Semin Oncol, 1997,2,4(2): S7-S23.
  • 9[9]Nagourney RA, Evans SS, Makalinao AJ, et al. Gemcitabine activity in primary cultures of human caner ( Abstract 2161 )[J]. Proc Am Assoc Cancer Res, 1996,37: 318.

共引文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部